Home » Topics » BioWorld Science

BioWorld Science
RSS

ETX-1317 restores the activity of cefpodoxime against beta-lactamase-producing UTI isolates

July 9, 2018

Arsanis describes monoclonal antibody binding Spa and Sbi which protects against S. aureus

July 9, 2018

New EGFR-TKI to treat T790M-mediated resistant lung cancers

July 9, 2018

Universiteit Twente presents an ITGA5-binding peptide for pancreatic cancer

July 9, 2018

Taking the STING out of autoimmunity

July 9, 2018

Introducing BioWorld Science: supporting R&D decisions through drug discovery and preclinical news

July 6, 2018

Takeda advances acquisition of TiGenix

July 6, 2018

Enzyvant partners with Visikol on digital pathology assay to support RVT-802

July 6, 2018

Regulus Therapeutics announces corporate restructuring

July 6, 2018

MHRA approves Xonvea in U.K. for nausea and vomiting of pregnancy

July 6, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...